Management von inadäquaten Schocks/T-Wellen-Oversensing bei S-ICD®-Patienten

  • Robert Larbig
  • Markus Bettin
  • Lukas J. Motloch
  • Alicia Fischer
  • Niklas Bode
  • Gerrit Frommeyer
  • Florian Reinke
  • Andreas Loeher
  • Lars Eckardt
  • Julia Köbe
Übersichten
  • 24 Downloads

Zusammenfassung

Inadäquate Schockabgaben sind eine gefürchtete Komplikation bei Patienten nach Implantation eines Kardioverter-Defibrillators, welche die Lebensqualität der betroffenen Patienten sehr stark beeinträchtigt. Die Ursachen von inadäquaten Schockabgaben beim subkutanen ICD (S-ICD®, Boston Scientific, Marlborough, MA, USA) sind vielfältig. Diese Übersichtsarbeit fasst die aktuelle Literatur zu diesem Thema zusammen und zeigt mögliche Behandlungsstrategien.

Schlüsselwörter

S-ICD® Inadäquate Schockabgaben Oversensing Programmierung Plötzlicher Herztod 

Management of inappropriate shocks/T-wave-oversensing in S-ICD®-patients

Abstract

Inappropriate shocks are a feared complication after implantable cardioverter–defibrillator (ICD) implantation and have a tremendous impact on quality of life. Inappropriate shocks in patients with subcutaneous ICD (S-ICD®, Boston Scientific, Marlborough, MA, USA) have various underlying causes. This review summarizes the current literature on this topic and lists possible treatment options.

Keywords

S-ICD® Inappropriate shocks Oversensing Programming Sudden cardiac death 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

Die Drs. M. Bettin, F. Reinke, J. Köbe, und, L. Eckardt haben Reisestipendien und Vortragshonorare von Biotronik, Boston Scientific, Medtronic, LivaNova, und St. Jude Medical erhalten. Drs. F. Reinke und L. Eckardt waren beide Mitglieder des Advisory Board von Cameron Health. R. Larbig, L.J. Motloch, A. Fischer, N. Bode, G. Frommeyer und A. Loeher geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Lambiase PD, Barr C, Theuns DA, Knops R, Neuzil P, Johansen JB et al (2014) Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S‑ICD Registry. Eur Heart J 35:1657–1665CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Boersma L, Barr C, Knops R, Theuns D, Eckardt L, Neuzil P et al (2017) Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study. J Am Coll Cardiol 70:830–841CrossRefPubMedGoogle Scholar
  3. 3.
    Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J et al (2015) ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015(36):2793–2867CrossRefGoogle Scholar
  4. 4.
    Kobe J, Hucklenbroich K, Geisendorfer N, Bettin M, Frommeyer G, Reinke F et al (2016) Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems. Clin Res Cardiol 106(5):317–321.  https://doi.org/10.1007/s00392-016-1055-0 CrossRefPubMedGoogle Scholar
  5. 5.
    Kooiman KM, Knops RE, Nordkamp OL, Wilde AA, de Groot JR (2014) Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T‑wave oversensing can be prevented: implications for management. Heart Rhythm 11:426–434CrossRefPubMedGoogle Scholar
  6. 6.
    Nordkamp OLR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ et al (2012) The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol 60:1933–1939CrossRefGoogle Scholar
  7. 7.
    Boveda S, Lenarczyk R, Haugaa K, Fumagalli S, Madrid AH, Defaye P et al (2016) Implantation of subcutaneous implantable cardioverter defibrillators in Europe: results of the European Heart Rhythm Association survey. Europace 18:1434–1439CrossRefPubMedGoogle Scholar
  8. 8.
    Brouwer TF, Yilmaz D, Lindeboom R, Buiten MS, Nordkamp OLR, Schalij MJ et al (2016) Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy. J Am Coll Cardiol 68:2047–2055CrossRefPubMedGoogle Scholar
  9. 9.
    Sousa MJ, Betts T (2017) Inappropriate shocks from a subcutaneous implantable cardioverter-defibrillator due to oversensing during periods of rate-related bundle branch block. J Arrhythm 33:73–75CrossRefPubMedGoogle Scholar
  10. 10.
    Lambiase PD, Gold MR, Hood M, Boersma L, Theuns DA, Burke MC et al (2016) Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts. heart Rhythm 13:1066–1074CrossRefPubMedGoogle Scholar
  11. 11.
    Frommeyer G, Dechering DG, Zumhagen S, Loher A, Kobe J, Eckardt L et al (2016) Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience. Clin Res Cardiol 105:89–93CrossRefPubMedGoogle Scholar
  12. 12.
    Batul SA, Yang F, Wats K, Shrestha S, Greenberg YJ (2017) Inappropriate subcutaneous implantable cardioverter-defibrillator therapy due to R‑wave amplitude variation: another challenge in device management. HeartRhythm Case Rep 3:78–82CrossRefPubMedGoogle Scholar
  13. 13.
    Maurizi N, Olivotto I, Nordkamp OLR, Baldini K, Fumagalli C, Brouwer TF et al (2016) Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy. Heart Rhythm 13(63):457CrossRefPubMedGoogle Scholar
  14. 14.
    Srinivasan NT, Patel KH, Qamar K, Taylor A, Baca M, Providencia R et al (2017) Disease severity and exercise testing reduce subcutaneous implantable cardioverter-defibrillator left sternal ECG screening success in hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol 10(4):e4801.  https://doi.org/10.1161/CIRCEP.117.004801 CrossRefPubMedGoogle Scholar
  15. 15.
    Maurizi N, Tanini I, Olivotto I, Amendola E, Limongelli G, Losi MA et al (2017) Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy. Int J Cardiol 231:115–119CrossRefPubMedGoogle Scholar
  16. 16.
    Morani G, Bolzan B, Tomasi L, Tomei R, Vassanelli C (2017) Pitfalls in electrogram interpretation: subcutaneous cardioverter defibrillator malfunction in brugada syndrome. Pacing Clin Electrophysiol 40(10):1180–1183.  https://doi.org/10.1111/pace.13091 CrossRefPubMedGoogle Scholar
  17. 17.
    Kamakura T, Wada M, Ishibashi K, Inoue YY, Miyamoto K, Okamura H et al (2017) Impact of electrocardiogram screening during drug challenge test for the prediction of T‑wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome. Heart Vessels 32(10):1277–1283.  https://doi.org/10.1007/s00380-017-0994-3 CrossRefPubMedGoogle Scholar
  18. 18.
    El-Chami MF, Harbieh B, Levy M, Leon AR, Merchant FM (2016) Clinical and electrocardiographic predictors of T wave oversensing in patients with subcutaneous ICD. J Arrhythm 32:181–185CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Gold MR, Theuns DA, Knight BP, Sturdivant JL, Sanghera R, Ellenbogen KA et al (2012) Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. J Cardiovasc Electrophysiol 23:359–366CrossRefPubMedGoogle Scholar
  20. 20.
    Bettin M, Larbig R, Rath B, Fischer A, Frommeyer G, Reinke F, Koebe J, Eckardt L (2017) Long-term experience with the subcutaneous ICD in teenagers and young adults. JACC Clin Electrophysiol.  https://doi.org/10.1016/j.jacep.2017.08.017 Google Scholar
  21. 21.
    Frommeyer G, Dechering DG, Kochhauser S, Bettin M, Koebe J, Eckardt L et al (2016) Long-time „real-life“ performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation. J Interv Card Electrophysiol 47:185–188CrossRefPubMedGoogle Scholar
  22. 22.
    Nordkamp OLR, Brouwer TF, Barr C, Theuns DA, Boersma LV, Johansen JB et al (2015) Inappropriate shocks in the subcutaneous ICD: incidence, predictors and management. int J Cardiol 195:126–133CrossRefGoogle Scholar
  23. 23.
    Afzal MR, Evenson C, Badin A, Patel D, Godara H, Essandoh M et al (2017) Role of exercise electrocardiogram to screen for T‑wave oversensing after implantation of subcutaneous implantable cardioverter-defibrillator. Heart Rhythm 14(10):1436–1439.  https://doi.org/10.1016/j.hrthm.2017.06.022 CrossRefPubMedGoogle Scholar
  24. 24.
    Cohen MI, Shaffer J, Pedersen S, Sims JJ, Papez A (2011) Limited utility of exercise-stress testing to prevent T‑wave oversensing in pediatric internal cardioverter defibrillator recipients. Pacing Clin Electrophysiol 34:436–442CrossRefPubMedGoogle Scholar
  25. 25.
    Brisben AJ, Burke MC, Knight BP, Hahn SJ, Herrmann KL, Allavatam V et al (2015) A new algorithm to reduce inappropriate therapy in the S‑ICD system. J Cardiovasc Electrophysiol 26:417–423CrossRefPubMedGoogle Scholar
  26. 26.
    Gold MR, Weiss R, Theuns DA, Smith W, Leon A, Knight BP et al (2014) Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator. heart Rhythm 11:1352–1358CrossRefPubMedGoogle Scholar
  27. 27.
    Clementy N, Challal F, Marijon E, Boveda S, Defaye P, Leclercq C et al (2017) Very high rate programming in primary prevention patients with reduced ejection fraction implanted with a defibrillator: Results from a large multicenter controlled study. Heart Rhythm 14:211–217CrossRefPubMedGoogle Scholar
  28. 28.
    Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J et al (2016) 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace 18:159–183CrossRefPubMedGoogle Scholar
  29. 29.
    Sovari AA, Ehdaie A, Liu Q, Wang X, Swerdlow C, Shehata M (2017) Ventricular tachycardia slower than the rate cut-off of a subcutaneous cardiac defibrillator sensed and successfully treated as a result of oversensing. HeartRhythm Case Rep 3:133–136CrossRefPubMedGoogle Scholar
  30. 30.
    Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP et al (2012) Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 367:2275–2283CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  • Robert Larbig
    • 1
  • Markus Bettin
    • 1
  • Lukas J. Motloch
    • 2
  • Alicia Fischer
    • 1
  • Niklas Bode
    • 1
  • Gerrit Frommeyer
    • 1
  • Florian Reinke
    • 1
  • Andreas Loeher
    • 3
  • Lars Eckardt
    • 1
  • Julia Köbe
    • 1
  1. 1.Division of Electrophysiology, Department of Cardiovascular MedicineUniversity of MuensterMünsterDeutschland
  2. 2.Department of Internal Medicine IIParacelsus Medical UniversitySalzburgÖsterreich
  3. 3.Department of Cardiac and Thoracic SurgeryUniversity of MuensterMuensterDeutschland

Personalised recommendations